Intelligence · INN directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Drugs in segment 1,035
Companies 800
Pipeline programs 335
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,035 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
ociperlimab
-
olodaterol
-
olverembatinib
-
orelabrutinib
-
orforglipron
-
pamiparib
-
pectin
-
penpulimab
-
pex168
-
pidotimod
-
promestriene
-
pucotenlimab
-
pyrotinib
-
refametinib
-
remifentanil
-
rezvilutamide
-
rhgm-csf
-
rivoceranib
-
rocbrutinib
-
ropivacaine
-
rotateq
-
sacituzumab
-
samrotecan
-
sar443122
Frequently asked questions
How many pipeline drugs are listed?
1,035 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.